Letrozole: Frequently Asked Questions Answered
What is letrozole?
Letrozole is a nonsteroidal aromatase inhibitor. It is used in anti-hormonal therapy for breast cancer by menopausal and post-menopausal women.
An excess of estrogen can lead to breast cancer. Letrozole works by blocking the aromatase enzyme. This is a key catalyst in converting the male hormone androgen into the female hormone estrogen.
Letrozole was first patented in 1986 and has been used for advanced breast cancer treatments since 1996. It is known better under the brand name Femara.
What are the uses of Letrozole?
We can divide the uses of letrozole under two main categories:
- Cancer treatment
- Letrozole is mainly used to treat breast cancer in menopausal women, particularly hormone-responsive, advanced cancer at the metastatic stage.
- It supplements tamoxifen. Tamoxifen is a drug that treats both premenopausal and post-menopausal cancer.
- Inducing ovulation
Letrozole can induce egg production in the ovaries and help in its release. Thus, it has uses as a fertility medication to stimulate ovulation in women who are unable to ovulate or aid in multiple egg production in those who can.